Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Equity Ratio (2024 - 2025)

Evommune (EVMN) has disclosed Equity Ratio for 2 consecutive years, with 0.91 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 148.19% to 0.91 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.91, a 148.19% increase, with the full-year FY2025 number at 0.91, up 148.19% from a year prior.
  • Equity Ratio was 0.91 for Q4 2025 at Evommune, up from 2.17 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.91 in Q4 2025 to a low of 2.17 in Q3 2025.